Subtle differences in the pathogenicity of SARS-CoV-2 variants of concern B.1.1.7 and B.1.351 in rhesus macaques
V. Munster, M. Flagg, M. Singh, B. Williamson, F. Feldmann, L. Perez-Perez, B. Brumbaugh, M. Holbrook, D. Adney, A. Okumura, P. Hanley, B. Smith, J. Lovaglio, S. Anzick, C. Martens, , E. de Wit
This study compares the pathogenicity of SARS-CoV-2 variants B.1.1.7 and B.1.351 in rhesus macaques, finding differences in clinical outcomes and immune responses.
bioRxiv · May 7, 2021Microbiology